$15.31
0.986.84%
Last update: Nov 9, 4:00 PM
Trevi Therapeutics Inc (TRVI) Stock Price, Quote, News & History
TRVINASDAQ
Trevi Therapeutics shares are trading higher after it announced pricing of its $150 million offering of 11.6 million shares at $13 per share.
You can purchase shares of Trevi Therapeutics (NASDAQ:TRVI) through any online brokerage.
Other companies in Trevi Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Trevi Therapeutics has a consensus price target of $22.28.
The stock price for Trevi Therapeutics (NASDAQ: TRVI) is $15.31 last updated November 9, 2026 at 4:00 PM EST.
There are no upcoming dividends for Trevi Therapeutics.
Trevi Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Trevi Therapeutics.
Trevi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary...
